Trk receptors: mediators of neurotrophin action.
By Ardem Patapoutian, L. Reichardt. Current Opinion in Neurobiology, 2001
1,115 citations recorded by the source corpus.
Subfields: Cancer Research, Cellular and Molecular Neuroscience, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/73f5a735cd74b31ce52c117fc99d40df1984fb7b
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Cellular and Molecular Neuroscience
In Molecular Biology
Citations in the corpus
- BDNF and activity-dependent synaptic modulation. (2003, background): “Activated receptors in general are capable of triggering a number of signal transduction cascades including the MAPK pathway, the phosphatidylinositol 3-kinase (PI3K) pathway, and the phospholipase C- (PLC- ) pathway (Kaplan and Miller 2000; Patapoutian and Reichardt 2001).”
- Brain-derived neurotrophic factor and its clinical implications (2015, background): “Trk receptor-mediated signaling is controlled through expression of intermediates in these signaling pathways that regulate localization of different signaling constituents [21–23].”
- Neurotrophin secretion: current facts and future prospects. (2003, background): “…between so called neuronal cell lines and primary neurons have often been described (see, e.g. PC12 cell survival versus neuronal survival; reviewed inKaplan and Miller, 2000; Patapoutian and Reichardt, 2001), and mixing up these two sets of data for NT secretion thus seems not to be appropriate.”
- Neurotrophins and their receptors: A convergence point for many signalling pathways (2003, background): “In addition to forming complexes, Trk and p75 receptors show independent signalling propertie”
- BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. (2005, background): “A growing body of evidence suggests an increase in the diversity and subcellular specificity of TrkB-coupled signaling pathways with maturation of the nervous system (Qian et al., 1998; York et al., 2000; Patapoutian and Reichardt, 2001).”
- Brain-derived neurotrophic factor. (2004, background): “Ligand-induced receptor dimerization results in kinase activation; subsequent receptor autophosphorylation on multiple tyrosine residues creates specific binding sites for intracellular target proteins, which bind to the activated receptor via SH2 domains (Barbacid, 1994; Patapoutian and Reichardt, ”
- Neurotrophin-regulated signalling pathways (2006, background): “Several excellent reviews describe recent progress in understanding the developmental and functional roles of these proteins (Bibel & Barde 2000; Huang & Reichardt 2001; Patapoutian & Reichardt 2001; Sofroniew et al. 2001; Dechant & Barde 2002; Chao 2003; Chao & Lee 2004; Lu et al. 2005).”
- Corneal nerves: structure, contents and function. (2003, background): “Mature neurotrophins exert their biological functions by binding to and activating two types of structurally unrelated transmembranous receptors: the low affinity p75 neurotrophin receptor (p75) and four members of the high affinity Trk receptor family of tyrosine kinases (Patapoutian and Reichardt,”
- Neuroblastoma: biological insights into a clinical enigma (2003, background): “cgi?l=4909">NT4 , also known as NT5) also seems to function through Trk”